Tenet's Q3 Net Income Plunges 27.5% Amid Lower Asset Sale Gains

Ticker: THC · Form: 10-Q · Filed: Oct 28, 2025 · CIK: 70318

Sentiment: bearish

Topics: Healthcare, Hospital Operations, Ambulatory Care, Earnings Decline, Asset Sales, Goodwill Increase, 10-Q Analysis

Related Tickers: THC, HCA, UHS, LPNT

TL;DR

**Tenet's Q3 earnings are a red flag, as the massive drop in net income, driven by a lack of asset sale gains, suggests a challenging path ahead without one-time boosts.**

AI Summary

Tenet Healthcare Corporation reported a decrease in net income available to common shareholders for the three months ended September 30, 2025, falling to $342 million from $472 million in the prior year, a 27.5% decline. For the nine months, net income available to common shareholders significantly dropped to $1,036 million from $2,882 million in 2024, a 64.1% decrease. This substantial decline is primarily attributed to a significant reduction in net gains on sales, consolidation, and deconsolidation of facilities, which were only -$4 million for the nine months ended September 30, 2025, compared to -$2,906 million in the same period of 2024. Net operating revenues saw a modest increase, reaching $5,289 million for the quarter and $15,783 million for the nine months, up from $5,126 million and $15,602 million respectively. Operating income also decreased to $889 million for the quarter and $2,655 million for the nine months, down from $1,089 million and $5,135 million in the prior year. The company's cash and cash equivalents decreased slightly to $2,975 million at September 30, 2025, from $3,019 million at December 31, 2024. Goodwill increased to $11,158 million from $10,691 million, primarily due to acquisitions in the Ambulatory Care segment.

Why It Matters

This significant drop in net income, largely driven by reduced gains from asset sales, signals a shift in Tenet's financial strategy or a lack of comparable high-value divestitures. For investors, this means a substantial decrease in earnings per share, impacting valuation and future dividend potential. Employees and customers might see less direct impact on day-to-day operations, but a less profitable company could eventually affect investment in facilities or staff benefits. In the competitive healthcare market, this performance could put Tenet at a disadvantage against rivals who are either growing organically or through more strategic acquisitions, potentially affecting its market share and long-term growth prospects.

Risk Assessment

Risk Level: medium — The substantial 64.1% decrease in nine-month net income available to common shareholders, from $2,882 million in 2024 to $1,036 million in 2025, is a significant concern. This decline is largely due to a -$2,906 million net gain on sales in 2024 compared to -$4 million in 2025, indicating a reliance on non-recurring gains in the prior year. While net operating revenues increased slightly, the core profitability without these asset sales is weaker.

Analyst Insight

Investors should scrutinize Tenet's organic growth drivers and future acquisition strategy, as the company's profitability appears heavily reliant on asset divestitures in previous periods. Consider if the current valuation adequately reflects a future without such substantial one-time gains, and evaluate the sustainability of its operating income trends.

Financial Highlights

revenue
$15,783M
operating Margin
16.8%
total Assets
$29,418M
total Debt
$13,187M
net Income
$1,036M
cash Position
$2,975M
revenue Growth
+1.2%

Revenue Breakdown

SegmentRevenueGrowth
Total Net Operating Revenues$5,289M+3.2%
Total Net Operating Revenues$15,783M+1.2%

Key Numbers

Key Players & Entities

FAQ

Why did Tenet Healthcare's net income available to common shareholders decrease so significantly in Q3 2025?

Tenet Healthcare's net income available to common shareholders decreased by 27.5% to $342 million in Q3 2025 from $472 million in Q3 2024. This substantial decline is primarily due to a significant reduction in net gains on sales, consolidation, and deconsolidation of facilities, which were only -$4 million for the nine months ended September 30, 2025, compared to -$2,906 million in the same period of 2024.

What were Tenet Healthcare's net operating revenues for the three and nine months ended September 30, 2025?

For the three months ended September 30, 2025, Tenet Healthcare reported net operating revenues of $5,289 million, an increase from $5,126 million in the prior year. For the nine months ended September 30, 2025, net operating revenues were $15,783 million, up from $15,602 million in the same period of 2024.

How did Tenet Healthcare's operating income change in the latest quarter?

Tenet Healthcare's operating income decreased to $889 million for the three months ended September 30, 2025, down from $1,089 million in the same period of 2024. For the nine months, operating income fell to $2,655 million from $5,135 million in the prior year.

What is the current status of Tenet Healthcare's cash and cash equivalents?

As of September 30, 2025, Tenet Healthcare's cash and cash equivalents stood at $2,975 million. This represents a slight decrease from $3,019 million reported at December 31, 2024.

What was the change in goodwill for Tenet Healthcare?

Goodwill for Tenet Healthcare increased to $11,158 million at September 30, 2025, from $10,691 million at December 31, 2024. This increase was primarily driven by goodwill acquired in the Ambulatory Care segment, which saw an increase of $467 million during the nine months ended September 30, 2025.

How many facilities does Tenet Healthcare's Ambulatory Care segment operate?

As of September 30, 2025, Tenet Healthcare's Ambulatory Care segment, primarily through USPI, held indirect ownership interests in 530 ambulatory surgery centers and 26 surgical hospitals. The company controlled 406 of these facilities and accounted for 150 under the equity method.

What are the key risks highlighted in Tenet Healthcare's 10-Q filing?

The 10-Q filing highlights several risks, including the impact of demand for qualified medical personnel on compensation costs, fluctuations in contractual allowances, managed care contract negotiations, cybersecurity incidents, and changes in federal and state healthcare regulations. The significant decrease in net gains from asset sales also indicates a risk related to the sustainability of past profitability drivers.

What was Tenet Healthcare's basic earnings per share for the nine months ended September 30, 2025?

Tenet Healthcare's basic earnings per share for the nine months ended September 30, 2025, was $11.37. This is a substantial decrease compared to $29.56 for the same period in 2024.

How much did Tenet Healthcare spend on repurchases of common stock during the nine months ended September 30, 2025?

During the nine months ended September 30, 2025, Tenet Healthcare repurchased $1,188 million of common stock. This is an increase from $672 million spent on repurchases in the same period of 2024.

What was the total amount of assets held for sale by Tenet Healthcare at September 30, 2025?

At September 30, 2025, Tenet Healthcare reported $82 million in assets held for sale. This is an increase from $21 million at December 31, 2024, and includes a building in West Palm Beach, Florida, classified as held for sale during the quarter.

Risk Factors

Industry Context

The U.S. healthcare industry is characterized by increasing consolidation, evolving reimbursement models, and significant regulatory oversight. Tenet operates in a competitive landscape with large hospital systems, specialized surgical centers, and urgent care providers. Key trends include a shift towards value-based care, technological advancements, and a growing demand for outpatient and ambulatory services.

Regulatory Implications

Tenet faces substantial regulatory scrutiny related to healthcare fraud and abuse, billing practices, and patient data privacy (HIPAA). Changes in government reimbursement rates (Medicare/Medicaid) and compliance with evolving healthcare laws are critical factors impacting financial performance and operational strategy.

What Investors Should Do

  1. Monitor the impact of facility consolidation and deconsolidation on earnings.
  2. Analyze the growth drivers within the Ambulatory Care segment.
  3. Evaluate the trend in operating income and margins.
  4. Assess the company's debt levels and interest coverage.

Glossary

Net operating revenues
The total revenue generated from the company's core business operations, excluding items like interest income or gains from asset sales. (Indicates the top-line performance of Tenet's healthcare services.)
Operating income
Profitability from core business operations before interest, taxes, and other non-operating expenses. (Measures the efficiency and profitability of Tenet's day-to-day operations.)
Goodwill
An intangible asset that arises when a company acquires another company for a price greater than the fair value of its identifiable net assets. (Represents the premium paid for acquisitions, primarily in the Ambulatory Care segment, and is subject to impairment testing.)
Noncontrolling interests
The portion of equity in a subsidiary that is not attributable to the parent company. (Represents the ownership stake of others in consolidated subsidiaries, impacting consolidated net income.)
Accumulated other comprehensive loss
A component of shareholders' equity that includes unrealized gains and losses on certain investments and foreign currency translations. (Reflects certain unrealized financial impacts on equity not yet recognized in net income.)
Redeemable noncontrolling interests
Represents the portion of equity in consolidated subsidiaries owned by third parties that is redeemable by those parties under certain conditions. (These interests have characteristics of both debt and equity and can impact the company's capital structure and future cash flows.)

Year-Over-Year Comparison

Compared to the prior year, Tenet Healthcare reported a notable decrease in net income available to common shareholders, down 27.5% for Q3 and a substantial 64.1% for the nine months. This decline is largely attributed to a significant reduction in net gains from facility sales. While net operating revenues saw a modest increase of 3.2% for the quarter and 1.2% year-to-date, operating income decreased significantly, indicating margin compression. Goodwill has increased due to acquisitions, while cash and cash equivalents have seen a slight decrease.

Filing Stats: 4,588 words · 18 min read · ~15 pages · Grade level 20 · Accepted 2025-10-28 16:06:53

Key Financial Figures

Filing Documents

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION Item 1.

Financial Statements (Unaudited)

Financial Statements (Unaudited) Condensed Consolidated Financial Statements 1 Notes to Condensed Consolidated Financial Statements 5 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 23 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 44 Item 4.

Controls and Procedures

Controls and Procedures 44

OTHER INFORMATION

PART II. OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 45 Item 1A.

Risk Factors

Risk Factors 45 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 45 Item 5. Other Information 45 Item 6. Exhibits 46 i Table of Contents

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS TENET HEALTHCARE CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS Dollars in Millions, Share Amounts in Thousands (Unaudited) September 30, December 31, 2025 2024 ASSETS Current assets: Cash and cash equivalents $ 2,975 $ 3,019 Accounts receivable 2,518 2,536 Inventories of supplies, at cost 346 346 Assets held for sale 82 21 Other current assets 1,889 1,760 Total current assets 7,810 7,682 Investments and other assets 2,939 3,037 Deferred income taxes 72 80 Property and equipment, at cost, less accumulated depreciation and amortization ($ 6,196 at September 30, 2025 and $ 5,809 at December 31, 2024) 6,091 6,049 Goodwill 11,158 10,691 Other intangible assets, at cost, less accumulated amortization ($ 1,357 at September 30, 2025 and $ 1,288 at December 31, 2024) 1,348 1,397 Total assets $ 29,418 $ 28,936 LIABILITIES AND EQUITY Current liabilities: Current portion of long-term debt $ 85 $ 92 Accounts payable 1,356 1,294 Accrued compensation and benefits 857 899 Professional and general liability reserves 287 238 Accrued interest payable 248 149 Liabilities held for sale 12 13 Income tax payable 28 18 Other current liabilities 1,687 1,607 Total current liabilities 4,560 4,310 Long-term debt, net of current portion 13,102 13,081 Professional and general liability reserves 891 900 Defined benefit plan obligations 296 298 Deferred income taxes 269 227 Other long-term liabilities 1,600 1,573 Total liabilities 20,718 20,389 Commitments and contingencies Redeemable noncontrolling interests in equity of consolidated subsidiaries 2,917 2,727 Equity: Shareholders' equity: Common stock, $ 0.05 par value; authorized 262,500 shares; 158,585 shares issued at September 30, 2025 and 158,001 shares issued at December 31, 2024 8 8 Additional paid-in capital 4,872 4,873 Accumulated other comprehensive loss ( 174 ) ( 180 ) Retained earnings 4,044 3,008 Common stock in treasury, at cost, 7

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing